Longeveron, Inc. (LGVN)
0.56
0.00 (0.00%)
USD |
NASDAQ |
Feb 20, 16:00
0.56
0.00 (0.00%)
After-Hours: 16:47
Longeveron EPS Diluted (Quarterly) : -0.393 for Sept. 30, 2025
EPS Diluted (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
EPS Diluted (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
EPS Diluted (Quarterly) Benchmarks
| ACADIA Pharmaceuticals, Inc. | 0.4206 |
| Agenus, Inc. | 1.944 |
| Alnylam Pharmaceuticals, Inc. | 1.368 |
| Savara, Inc. | -0.1366 |
| Arrowhead Pharmaceuticals, Inc. | 0.219 |
EPS Diluted (Quarterly) Related Metrics
| Net Income (Quarterly) | -7.221M |
| Revenue (Quarterly) | 0.137M |
| Total Expenses (Quarterly) | 7.358M |
| Enterprise Value | 3.685M |
| Gross Profit Margin (Quarterly) | -102.2% |
| Profit Margin (Quarterly) | -5.27K% |
| Earnings Yield | -238.8% |
| Normalized Earnings Yield | -238.77 |